Background: Organophosphates (OP) are a diverse group of insecticides used for pest control. Due to easy availability of these compounds over the counter, organophosphate poisoning continues to be a major cause of deliberate self-harm. Although choline esterase inhibition plays a key role in OP poisoning, other metabolic factors like dysglycemia contribute to the severity of poisoning. The present study attempts to assess glycaemic variability as a probable prognostic factor in acute OP poisoning. Aim of the study was to correlate the blood glucose levels with the severity and treatment outcome of acute organophosphate poisoning.Methods: 100 patients of acute organophosphate poisoning admitted in the hospitals affiliated to Bangalore Medical College and Research Institute during the study period from August 2018 to July 2019, were enrolled into the study as per the inclusion criteria and graded into mild, moderate & severe, based on Peradeniya organophosphorus poisoning (POP) scale. Random blood sugar (RBS) was estimated at the time of admission and patients were followed up till recovery/death.Results: The patients in this study were categorized into hypoglycemics (10%), euglycemics (75%) and hyperglycemic (15%). 16% of euglycemics, 30% of hypoglycemics and 60% of hyperglycemics had severe grade of poisoning. The ventilator requirements in hypoglycaemics, euglycemics and hyperglycemics were 40%,48% and 80% respectively. The outcome in terms of mortality was 8% in euglycemics group and 20% in hyperglycemics group. Hence hyperglycemia was found to be a poor prognostic marker in acute organophosphate poisoning.Conclusions: RBS at admission in acute organophosphate poisoning patients is a simple, inexpensive tool that may help to predict the clinical outcome. Early identification of the poor prognostic indicators may help in timely intervention, to reduce morbidity and mortality, especially in a resource limited country like India.
Background: Cervical cancer is the most common cancer among india women and age standardized mortality rate are the highest in south central Asia. In the past decade an among aetiologic association between infection with high risk human papilloma virus and development of cervical cancer has been increased. The study was aimed at studying the prevalence and determinants of high risk human papilloma virus in these patients. Methods: This study was conducted for a period of one year to know the prevalence and determinants of high risk human papilloma virus in the patients attending gynaec out patient department. A total of 266 married women between 15-75 were randomly selected for the study. Results: There is high prevalence of HPV in low (43.3%)/mid (37.4%) socio economic class (17.6%). But the result was not statistically significant (p=0.149). higher prevalence of HPV was found in multiparas (39.4%) compared to multiparas (33.3%) which was not statistically significant (p=0.233). Husbands of 252 women were circumcised out of which 96 wives were positive for HPV DNA (38.1%). Among 14 women with no history of circumcision in their husband HPV DNA positive (28.6%). Correlation of cytology with HPV DNA among different age groups showed increasing prevalence with age but the result was not statistically significant (p=0.115). the result showed that age at marriage, higher the prevalence of HPV DNA. The result was statistically significant (p=0.017). with increasing state of education, the prevalence of HPV infection decreased, but the result was not statically significant (p=0.142).51.3% of women of who were not education were positive for HPV as against only 25% of graduates were HPV positive. Conclusions: Genital hygiene, genetic polymorphisms and other environmental cofactors among HPV DNA positive women, which prevent oncogenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.